Detalhe da pesquisa
1.
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.
BMC Cancer
; 22(1): 494, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513774
2.
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.
Mod Pathol
; 34(8): 1596-1607, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33854184
3.
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.
Am J Surg Pathol
; 48(2): 163-173, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994665
4.
Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma.
Hum Pathol
; 134: 102-113, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581128
5.
Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms.
Int J Surg Pathol
; 31(6): 1027-1040, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250542
6.
Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms.
Hum Pathol
; 130: 95-109, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36511267